Since our results identify a gene-disease interaction that alters mortality specifically in the diabetic population after cardiac ischemia, they suggest that a therapeutic approach targeting PPAR-responsive genes and metabolic pathways might favorably affect outcomes. Here, PPARA is linked to myocardial ischemia.